Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Four molecule families have peer-reviewed clinical evidence supporting their use in microinfusion-style delivery: copper tripeptide GHK-Cu (collagen synthesis, gene-expression modulation), recombinant epidermal growth factor or sh-Oligopeptide-1 (keratinocyte proliferation, dermal restructuring), polydeoxyribonucleotide PDRN (adenosine A2A receptor activation, fibroblast stimulation, anti-melanogenesis), and a multi-molecular-weight hyaluronic acid system (50 kDa to 2000 kDa fractions, each with different penetration depth and biological role)
Track symptoms and get AI-powered recommendations for dose adjustments
The peptide blocks NF-kB activation, a master switch for inflammatory gene expression
It may, however, increase the likelihood of side effects
No health claims are made unless supported by multiple peer-reviewed studies
It works by: Enhancing flexibility and reducing inflammation
US$ 23.86
US$ 24.77
US$ 27.90
US$ 26.25
US$ 27.33
